GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: formula IIIb [WO2023177592] | HBI2375 | HYBI-084
Compound class:
Synthetic organic
Comment: HBI-2375 acts as an inhibitor of the protein-protein interaction between MLL1 and WDR5 [1]. This is a molecular mechanism that is proposed for the elimination of cancer stem cells in certain tumours. It is brain-penetrant, but lacks potency in functional studies using leukemia cells (GI50 > 3μM). HBI-2375 is identified as HBI-2375/HYBI-084 in patent WO2023177592A1 [2].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel